A detailed history of Mcf Advisors LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 21 shares of CTLT stock, worth $1,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 21 -0.0%
Holding current value
$1,333
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$42.56 - $59.82 $170 - $239
4 Added 23.53%
21 $1,000
Q4 2023

Feb 01, 2024

SELL
$32.18 - $46.57 $2,542 - $3,679
-79 Reduced 82.29%
17 $0
Q3 2023

Oct 19, 2023

BUY
$44.2 - $50.2 $3,005 - $3,413
68 Added 242.86%
96 $4,000
Q4 2022

Jan 31, 2023

BUY
$41.39 - $81.0 $1,158 - $2,268
28 New
28 $1,000
Q2 2019

Aug 06, 2019

SELL
$39.26 - $54.21 $3,140 - $4,336
-80 Closed
0 $0
Q4 2018

Jan 25, 2019

SELL
$29.95 - $46.34 $209 - $324
-7 Reduced 8.05%
80 $2,000
Q3 2018

Oct 24, 2018

BUY
$40.12 - $45.55 $3,490 - $3,962
87 New
87 $4,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.